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a  b  s  t  r  a  c  t
Aids  patients  were  treated  during  a year  with  three  different  food  supplements  commercially  avail-
able:  para-pau-aspido  (Aspidosperma  subincanum  Mart. ex A.  DC.,  Apocynaceae);  2Leid (nucleic  acids  and
cytokines);  and  Para  Immuno  (propolis,  pollen  and  royal  jelly).  All foods,  given  either  alone  or  in  com-vailable online 11 February 2015
eywords:
leine
IV
ri-therapy
bination,  proved  useful  to all AIDS  patients  who  received  the  supplements,  be  these  under tri-therapy
(Triomine:  stavudine,  lamivudine,  névirapine)  or left  unattended.
© 2014  Sociedade  Brasileira  de  Farmacognosia.  Published  by  Elsevier  Editora  Ltda.  All rights  reserved.ibonucleic Acid Oligomers (RNO)
ntroduction
The treatment of AIDS patients rests on the administration
f three chemicals designed to reduce the viral load. The HIV is
mmunodepressive but no effort is made during chemical treat-
ent to stimulate the multiplication and activity of lymphocytes.
his stimulation would however beneﬁt the patients because some
rugs are known to be immunosuppressive, which add to the
mmunodepression induced by the pathogen. Means exist to stimu-
ate the immune response, either by inducing the synthesis of nitric
xide by lymphocytes and other cells, or else by promoting the
ultiplication of lymphocytes.
Uleine (1), present in Himatanthus lancifolius and Aspidosperma
ubincanum Mart. ex A. DC., Apocynaceae, have been extensively
tudied (Seidl et al., 2010). Its capacity to promote the synthesis of
itric oxide (Souza et al., 2007) makes of these plants candidates
or use as an adjuvant in the treatment of patients suffering from
n immune-depression. The bark of Aspidosperma subincanum has
een puriﬁed and the food supplement rich in uleine so obtained
as been demonstrated innocuous (Federlin et al., 2014).
Nucleic acid oligomers have been shown to inhibit in vivo Shope
broma and vaccinia viruses (Beljanski et al., 1975). This effect was
raced to a stimulation of the multiplication of lymphocytes and
latelets (Beljanski and Plawecki, 1979). Lymphocyte populations
epleted in vivo by cyclophosphamide responded to a stimulus of
ibo-oligo-nucleotides (Beljanski et al., 1983). This positive effect of
∗ Corresponding author.
E-mail: anda.mars@wanadoo.fr (R. Maes).
http://dx.doi.org/10.1016/j.bjp.2014.11.011
102-695X/© 2014 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editoraregeneration of lymphocytes by nucleic acids observed in vivo was
veriﬁed on two malignant lymphoma cases (Donadio et al., 1991).
These food supplements would appear useful to help the
immune system of immuno depressed patients as tuberculosis
and Aids patients to counter the immunodepressive activity of
the pathogens as well as the immunodepressive activity of some
drugs used to eliminate the pathogen. This hypothesis was veriﬁed
by administering the supplements during a year to AIDS patients.
In addition, a third food supplement consisting of propolis, royal
jelly and pollen, known to stimulate the immune system, was also
offered to the clinician, enabling her to make a complete study of
available immuno stimulators.
The clinician focused on the improvement of the health of her
patients by verifying the activity of a combination of food sup-
plements given to patients either under chemical treatment or
else, due to lack of resources, left unattended. Lack of resources
restricted the monitoring in the course of time of the effects of the
treatments, to weight and lymphocyte numbers.
The detailed raw results (66 pages) are available (Bouillon and
Ndayikunda, 2006). The authors analysed and exploited them.
Materials and Methods
Uleine source and the immunostimulant
Uleine (1) was extracted from the plant Aspidosperma subin-
canum Mart. ex A. DC., Apocynaceae, and presented as the food
supplement “Para-pau-aspido” by the Company Parabolic Biologi-
cals (Beauvechain, Belgium) under two  different concentrations:
PP20 (20 mg  total alkaloids) and PP 80 (80 mg  total alkaloids).
 Ltda. All rights reserved.
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 supply of the products sufﬁcient to cover a year of treatment
as donated. The food supplement “Para Immuno” elaborated by
he Company Parabolic biologicals was made of propolis extracted
rom bee-hives, Royal Jelly and pollen. This product was  donated
n amounts sufﬁcient to cover a year of treatment.
2Leid is prepared by the laboratory “Laboratoire Labo-Life”. This
mmunostimulant to be taken sub-lingually is made of cytokines,
ibonucleic acids, deoxyribonucleic acids and TGFbeta, and the
roduct was donated in amounts sufﬁcient to cover a year of treat-
ent.
Triomine 530: stavudine 30 mg,  lamivudine 150 mg,  névirapine
0 mg,  for patients whose weights was inferior to 60 kg.
Triomine 540: stavudine 40 mg,  lamivudine 150 mg,  névirapine
00 mg,  for weights over 60 kg.
linical studies
Number of subjects treated was eighty, of whom sixty were
ncluded in this study. They were orphans at the orphanage “Maison
halom”, located in the Burundi.
The ﬁles of the patients were a year old when the study
as initiated in 2006 and many showed an unfavourable clinical
ymptomatology and opportunist infections, i.e. chronic diarrhoea,
ersistent fever, generalised lymphadenopathies, diverse pneu-
opathies, mycoses, generalised dermatoses, zona, alteration of
he general state, loss of weight and asthenia. Nearly all patients had
onserved their symptomatology when the treatment with supple-
ents started and some had worsened and developed additional
pportunist infections.
Among the subjects under tri-therapy since six months, some
howed no clinical change, others had developed new oppor-
unist illnesses and others were intolerant to the tri-therapy. Those
atients under tri-therapy who showed no improvement and who
ad developed opportunistic infections that were not observed
efore the chemical treatment, were included in the study.
CD4’ were monitored at time one year before treatment (T-1)
nd at the initiation of the treatment (T0) but this monitoring could
ot be pursued. Weight and total lymphocyte numbers were moni-
ored one year before treatment (T-1), at time 0 (T0), 3 months (T3)
nd 12 months (T12) after initiation of food supplement treatment.
reatment was stopped at T12.
The food supplement was approved by the Belgian Ministry of
ealth on June 23 2009 and does not require the approval of an
thics committee for its use.
esults
Table 1 presents results of fourteen patients who  were under
onventional tri-therapy for about six months before addition
f the food supplements to the treatment. Their state of illness
as advanced. The regimen was given according to the medical
mperatives deﬁned by the treating physician. Three very ill
atients under tri-therapy who died either at the beginning of
he treatment or within the ﬁrst three months of treatment were
mitted because treatment with food supplements is a long-term
rocess that could not have been effective at their stage of the
llness. Table 2 shows the results of 46 AIDS people who wereFarmacognosia 25 (2015) 42–46 43
without speciﬁc medical treatment. Their state of illness was less
severe than the patients under tri-therapy. The results obtained by
patients under tri-therapy are presented at some length because
these results are most interesting.
Patients under tri-therapy
P.P 80, 2Leid and P.I. and tri-therapy
The ﬁrst four patients (Nbs. 1 to 4) were in a critical physical
condition at time zero (T0) and received the combination [P.P 80
+ 2Leid + P.I. + tri-therapy]. Patient 1 was a 19-year old girl. She
weighed 30 kg at the beginning of the treatment (T0) and the num-
ber of CD4 cells had collapsed down to 6. Evidently, she did not
beneﬁt from the tri-therapy and seemed doomed. In three months
of food supplements intake (T3), she gained 15 kg and her num-
ber of total lymphocytes increased from 212 to 2915. She was in
good health at T12, after 12 months of the additional alternative
treatment.
The tri-therapy followed from time T-1 to T0 appeared more
beneﬁcial to patients 2 to 4 because they maintained or even
slightly increased in weight during that time and had retained their
CD4 and lymphocyte levels, albeit in very low numbers. The food
supplements [P.P 80 + 2Leid + P.I. and tri-therapy] caused a dramatic
gain in weight. More importantly, there was  a spectacular increase
in the number of their total lymphocytes. All were in a satisfactory
state of health after 12 months of food supplements intake.
P.P.80, 2Leid and tri-therapy
Patients 5 to 8 received only P.P.80 + 2Leid, in addition to the
chemicals. They were in a very poor state of health before start-
ing food supplementation: severe drops in CD4 counts, except in
patient 8, low weight and low lymphocyte count. The tri-therapy
had proven ineffective. After three months of food supplement
intake [P.P.80 + 2Leid + tri-therapy], lymphocyte counts increased
dramatically and 3 out of 4 patients had a signiﬁcant gain in weight.
Patient 6 also gained weight after 12 months of alternative therapy
and all were in a satisfactory state of health at that moment (T12).
PP 80 and tri-therapy
Patients 9 to 12 received P.P.80 in addition to the tri-therapy.
Patients 9 and 10 were clinically speaking in a “stable state”, with
relatively high CD4 and lymphocyte counts at time T0. The weight
of patient 9 was not measured before the start of the study, but
patient 10 had a stable weight. By contrast, patients 11 and 12 had
low CD4 counts despite tri-therapy and had lost weight. The tri-
therapy had proven inefﬁcient. Three months after they started to
take the P.P.80 food supplement, their weight and their lymphocyte
counts had increased. After twelve months of treatment with the
food supplement, their health was  good.
PP20, Para Immuno and tri-therapy
This regimen was given to patient 13, a 15-years old girl weigh-
ing 24 kg at the time of her admission in the orphans’ home, under
chemo-therapy but with diarrhea, fever and pneumopathy and
having lost ¾ of her CD4’s during chemical treatment, recovered
when P.P.20 and P.I. was  given during three months. The use of
P.P.20 instead of P.P.80, a 4-fold lower dose in active principles,
resulted in a similar weight gain and lymphocyte count recovery
as with the previous 12 patients, indicating that this lower dosage
was just as efﬁcacious, at least in a teenager.Patient 14, under tri-therapy and receiving only 2Leid as food
supplement had a moderate CD4 cell count but was losing weight
before joining the study. Three months later, she had not only
recovered but gained weight and her lymphocyte count had
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Table 1
Fourteen AIDS patients under conventional tri-therapy. These patients were advanced in disease, with only #9 and #10 in a conserved state. For this reason, they were
chemically-treated but the treatment sometimes worsened their condition, shown by a loss in weight (e.g. #2, 11, and 14, or else a status quo: e.g. #5, #6, #10). Some
underwent a severe loss of CD4 during the treatment: e.g. #6, #7, #11, #12). All gained in lymphocytes numbers during food supplement treatment.
Patient Treatment Symptoms Weight Viral L CD4 Lymphocytes
N◦ File Age Sex PP 2Leid P.I. T0 T-1 T0 T3 T12 T-1 T-1 T0 T0 T3 T12
1 LB 42 19 F 80 yes yes 3, 5, 16, 17 30 45 51 6 212 2915 3600
2  LA02 26 F 80 yes yes 3,6,5 55 50 62 69 120000 84 80 131 2760
3  LA49 34 F 80 yes yes very bad 46 51 62 70 125000 25 24 802 2615
4  LA50 36 F 80 yes yes very bad 56 62 72 83 125000 62 56 904 2464
5  LA18 20 F 80 yes 3,4, very bad 44 45 60 80 140000 34 2 151 1768 2916
6  LB41 20 M 80 yes 3,4, very bad 60 60 61 66 0 611 90 402 1915 2690
7  LA32 32 F 80 yes 3,4, very bad 44 46 56 60 98650 245 40 806 2900 3050
8  LA35 37 F 80 yes 3,4, very bad 47 55 72 79 150000 16 127 679 2464
9  LB33 12 F 80 Conserved 30 32 53 191 720 1920 4500
10  La15 21 F 80 conserved state 59 60 65 76 20000 200 204 1504 2115 3915
11  LA06 30 F 80 2,3, 5, 6 46 40 53 67 120000 95 59 300 1584 3900
12  LA23 31 F 80 3, 13,6,5, 55 50 66 75 135000 50 60 800 2160 3916
13  LA31 15 F 20 yes 3, 6, 5 24 26 33 40 0 435 100 802 2005 3050
14  LA07 23 F yes 6, 3, 11 45 40 52 64 10 000 300 1401 2500 3900
Viral L: viral load.
Treatments: PP: para aspido, 20 or 80 units; 2Leid: cytokines and nucleic acids; PI: royal jelly, propolis, pollen. Tritherapy: stavudine, lamivudine, nevirapine
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tymptoms: 1. congenital; 2. adenopathy; 3. diarrhea; 4. dermatitis; 5. pneumopathy
sychomotor delay; 13. lymphadenopathy; 14. candidiasis; 15. vomiting; 16. hepat
oubled. These results are comparable to those observed in the
ther 13 patients.
atients without tri-therapy
A larger number of patients (Table 2: Nb 15 to 60) received no
ri-therapy. The clinician deﬁned their health status at time zero
y qualitative criteria (conserved, good, bad etc.) and took note of
pportunist infections. The loss of weight in these AIDS patients
rom the moment of their admission in the orphans’ home (T-1) to
ime zero (T0), i.e.  a year later when food supplementation started,
s an objective sign of their evolution, as is their viral load and the
evel of their CD4’. Some of them, especially young children, gained
eight and increased the number of CD4 while others saw a decline
n their CD4 between T-1 and T0, but only two of them (Nbs 29 and
1) had CD4 levels below the 100 mark at time T0.
Table 2 shows that, irrespective of the severity of their illness
nd the worsening of their physical condition during the year that
receded supplement treatment, all recovered and gained weight
n addition to increasing their total lymphocyte count. All were in
atisfactory or good health at the end of the twelve-month course
f food-treatment. If the effects of this treatment are visible after
hree months in most of the treated AIDS people, some however
eeded more than three months of food supplement intake before
howing clear evidence of recovering health (Nbs 21, 27, 56) even
f an increase in numbers of total lymphocytes took already place
t time T3.
iscussion
During the whole year of treatment with natural products, we
eplored no collateral secondary effects except two patients on
P80, who signalled a nose blooding that disappeared after the end
f the treatment. This evidence of innocuity corroborates the results
btained in animal studies (Federlin et al., 2014).
All applied protocols proved efﬁcacious. The uleine boosts the
ynthesis of nitric oxide, the ribonucleotides stimulate the multipli-
ation of lymphocytes and the Para Immuno (propolis, Royal jelly
nd pollen) stimulates the immune system. A combination of all
hree works best in as much that every facet of the global treatment
as exploited. However, the single application of uleine to non-
reated patients, be it at its highest or lowest concentration, yieldedyperthermy; 7. Inappetence; 8. shingles; 9. otitis; 10. pharyngitis; 11. coughing; 12.
7. sarcoma.
remarkable results by itself. Patients 26, 27 and 28, who  were given
PP80, showed a substantial improvement of their condition, at a
par with that observed when complete regimens were given. This
observation is valid also for patients 47 to 51, who received PP20:
their condition improved at the same rate as patients handled with
the two additional food supplements. The chemically unattended
patients were generally in a better condition (i.e. said “conserved”)
than those who  were under treatment. In this group, patients 9,
10, 11 and 12 gained no weight during chemical treatment or
else lost weight. Yet, PP80 given alone to them in addition to tri-
therapy improved considerably their health. An explanation for this
remarkable effect may  be found in the fact that uleine also inter-
feres with the inﬂammatory response (Nardin et al., 2008) and reg-
ulates the immune system (Nardin et al., 2010). The substance pos-
sesses thus properties shared by the two other regimen proposed.
One must note here that a reduction in the number of pills taken,
and in the frequency of their administration, must be favoured in
all cases not only for reasons of cost and burden but because it plays
a considerable positive role on the psychology of the patients.
The progress registered initially on the clinical level by nearly
all patients receiving food supplements was conﬁrmed by a signiﬁ-
cant increase of total lymphocytes numbers and weight increase
from the 3th month on. Patients under tri-therapy progressed
most obviously at the level of secondary effects and opportunis-
tic infections. In 2006, at the end of the supplement treatment, we
registered no case of diarrhoea, no case of hyperthermia, no case
of dermatose or other opportunistic illnesses. We had only three
deaths by pneumocytosis, meningitis and bacterial pneumopathy
but these were very advanced cases at the beginning of the treat-
ment.
The patient under tri-therapy were given food supplements
when they showed no improvement and/or developed oppor-
tunistic diseases that did not exist before the treatment with the
anti-retrovirals. A tri-therapy based on stavudine, lamivudine and
nevirapine is a heavy treatment that often causes secondary effects
in the patient and can be a factor of health degradation in many
treated subjects. Our results indicate that tri-therapy worsens the
health of some AIDS patients instead of improving it, while tak-
ing food supplements not only does not cause the same negative
effects but can help the patients get over those produced by con-
ventional therapy and even cause partial recovery of AIDS patients
not receiving it.
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Table  2
46 patients receiving no standard chemical therapy. Some patients were with opportunistic diseases but a sizable number were in good state or “conserved”. All of them saw
the  number of their lymphocytes increase during treatment.
Patient Treatment Symptoms Weight Viral L. CD4 lymphocytes
N◦ File Age Sex P.P. 2Leid P.I. T0 T-1 T0 T3 T12 T-1 T-1 T0 T0 T3 T12
15 LB52 15 F 80 yes yes 3, 6, bad 45 30 35 45 0 610 924 1802 2720
16  LC03 17 F 80 yes yes conserved 44 54 60 1121 3915
17  LB64 19 F 80 yes yes conserved 58 69 73 1215 2280
18  LB60 20 F 80 yes yes good state 59 50 60 65 0 488 1320 3916 4200
19  LA21 23 F 80 yes yes good state 51 54 60 66 75000 95 420 1420 2850 3915
20  LA36 31 F 80 yes yes good state 60 65 73 81 0 500 318 1412 4080
21  LC02 35 F 80 yes yes 3,6, 14, bad 40 42 76 902
22  LB23 20 F 80 yes conserved 60 65 70 74 6000 296 315 1390 2500 3920
23  LA20 21 F 80 yes +/-’ good 48 52 58 64 122000 50 105 1240 1539 2620
24  LA39 35 F 80 yes conserved 40 45 65 75 120000 25 312 1219 2900 3620
25  LC04 M 80 yes 3, 6, 17 50 60 65 502 2108
26  LB30 20 F 80 conserved 35 50 61 66 10000 205 310 1311 2530 3910
27  LB19 20 F 80 good state 60 65 66 75 0 391 320 1301 1320 3900
28  LA33 30 F 80 conserved 46 50 60 65 100050 250 360 1250 2500 3200
29  LA13 3 F 20 yes yes 3, 6, 5, 12 6 7 12 18 130 000 80 60 1201 2100 4610
30  LA45 3 F 20 yes yes good state 7 12 17 23 125000 25 391 1210 4608 5105
31  LA26 9 M 20 yes yes good state 14 16 20 36 0 420 402 1240 2100 4112
32  LA08 10 F 20 yes yes 6, 3, 7, 4, 9 21 21 30 46 6 000 300 277 1314 3915 4904
33  LA44 10 F 20 yes yes good state 14 20 30 37 125000 85 420 1311 3016 3620
34  LA05 12 F 20 yes yes 1, 6, 3, 8 28 29 35 51 12 000 250 277 1360 3005 4915
35  LA09 12 F 20 yes yes 1, 9, 4 25 25 38 45 0 350 244 1901 2615 3916
36  LB53 13 M 20 yes yes very bad 13 20 25 612 3360 4600
37  LA04 14 F 20 yes yes 5, 8 31 28 35 43 .50.000 140 130 1211 2900 4190
38  LA40 14 F 20 yes yes good state 16 20 30 46 53500 250 305 1229 3050 4215
39  LA01 11 M 20 yes 2,3, 4, 5, 10 26 24 30 35 80 500 120 100 711 2110
40  LB46 21 F 20 yes conserved 59 65 75 226 1247 3024 4500
41  LA27 4 M 20 yes good 11 11 15 21 0 500 305 1321 1910 2915
43  LA41 10 M 20 yes good 16 20 26 40 25000 350 315 1319 3600 4250
44  LA17 11 M 20 yes +/-’ good 15 20 25 35 130000 100 60 405 1120 2905
45  LA30 13 M 20 yes conserved 19 21 31 36 0 600 372 1120 2820 3912
46  LA03 15 F 20 yes 3,7 45 41 50 60 110 000 91 300 1707 2910 4210
47  LA43 9 F 20 good 13 20 25 36 15000 350 416 1620 2600 3950
48  LA29 11 M 20 conserved 24 25 30 36 0 480 450 1200 2912 4045
49  LB35 12 F 20 conserved 19 22 29 35 0 412 383 827 1460 2920
50  LB32 13 F 20 Conserved 30 32 40 45 5000 490 259 561 1768 2900
51  LB13 19 M 20 good state 60 62 75 79 0 526 620 1302 4901
52  LA10 21 F yes yes 60 55 61 72 30 000 200 1500 2500 4600
53  LB04 3 F yes 3 12 12 15 26 0 710 1400 3500
54  LB02 4 F yes 3,6, delayed growth 12 13 18 24 0 420 1830 2930
55  LB17 5 F yes 3, 15, 14 18 18 25 30 0 518 1150 3900 4600
56  LB08 7 F yes 6,14 18 18 25 37 0 520 1200 4500
57  LB21 21 F yes 3, 6, 7 60 42 45 50 0 620 1950 2500 3600
58  LA25 25 F yes 3,4,14 44 45 60 65 10000 360 1300 3900 4115
59  LA22 26 yes conserved state 55 50 61 67 8000 300 1200 2700 4105
60  LA47 33 F yes 3, 6, 5 tuberc. 52 51 61 71 5500 350 1250 2950 3920
LA38  33 M yes conserved state 46 46 55 66 60000 300 1220 2915 2400
Viral L: viral load.
Treatments: PP: para aspido, 20 or 80 units; 2Leid: cytokines and nucleic acids; PI: royal jelly, propolis, pollen. Tritherapy: stavudine, lamivudine, nevirapine
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